Protection of Salivary Function by Concomitant Pilocarpine During Radiotherapy: A Double-Blind, Randomized, Placebo-Controlled Study

International Journal of Radiation Oncology Biology Physics

Volumn 70, Issue 1, 2008, Pages 14-22

  Burlage, Fred R ^a   Roesink, Judith M ^b   Kampinga, Harm H ^a   Coppes, Rob P ^a   Terhaard, Chris ^b   Langendijk, Johannes A ^a   van Luijk, Peter ^a   Stokman, Monique A ^a   Vissink, Arjan ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Dose volume response; Pilocarpine; Radiation induced xerostomia; Randomized study

Indexed keywords

ONCOLOGY; RADIOTHERAPY; RANDOM PROCESSES; TUMORS;

DOSE VOLUME RESPONSE; PAROTID GLAND DYSFUNCTION; PILOCARPINE; RADIATION INDUCED XEROSTOMIA;

DRUG PRODUCTS;

PILOCARPINE; PLACEBO;

ADULT; ARTICLE; CANCER RADIOTHERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HEAD AND NECK CARCINOMA; HISTOGRAM; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIATION DOSE; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SALIVARY GLAND FUNCTION; SCORING SYSTEM; XEROSTOMIA;

ADOLESCENT; ADULT; AGED; CARCINOMA, SQUAMOUS CELL; DOUBLE-BLIND METHOD; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; MUSCARINIC AGONISTS; ODDS RATIO; PAROTID GLAND; PILOCARPINE; PROSPECTIVE STUDIES; RADIATION INJURIES; RADIOTHERAPY DOSAGE; REGRESSION ANALYSIS; SWEATING; XEROSTOMIA;

EID: 37049031461     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.06.016     Document Type: Article

References (24)

1. Vissink A., Jansma J., Spijkervet F.K.L., et al. Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14 (2003) 199-212
2. Burlage F.R., Coppes R.P., Meertens H., et al. Parotid and submandibular/sublingual salivary flow during high dose radiotherapy. Radiother Oncol 31 (2001) 271-273
3. Eisbruch A., Ten Haken R.K., and Kim H.M. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity modulated irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
4. Roesink J.M., Moerland M.A., Battermann J.J., et al. Quantitative dose-volume response analysis of changes in parotid gland function after radiotherapy in the head-and-neck region. Int J Radiat Oncol Biol Phys 51 (2001) 938-946
5. Chao K.S., Deasy J.O., Markman J., et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three dimensional radiation therapy: Initial results. Int J Radiat Oncol Biol Phys 49 (2001) 907-916
6. Eisbruch A., Kim H.M., Terrell J.E., et al. Xerostomia and its predictors following parotid-sparing irradiation of head-and-neck cancer. Int J Radiat Oncol Biol Phys 50 (2001) 695-704
7. Braaksma M.M., Wijers O.B., van Sornsen de Koste J.R., et al. Optimisation of conformal radiation therapy by intensity modulation: Cancer of the larynx and salivary gland function. Radiother Oncol 66 (2003) 291-302
8. Saarilahti K., Kouri M., Collan J., et al. Intensity modulated radiotherapy for head and neck cancer: Evidence for preserved salivary gland function. Radiother Oncol 74 (2005) 251-258
9. Valdez I.H., Wolff A., Atkinson J.C., et al. Use of pilocarpine during head and neck radiation therapy to reduce xerostomia and salivary gland dysfunction. Cancer 71 (1993) 1848-1851
10. Zimmerman R.P., Mark R.J., Tran L.M., et al. Concomitant pilocarpine during head and neck irradiation is associated with decreased posttreatment xerostomia. Int J Radiat Oncol Biol Phys 37 (1997) 571-575
11. Lajtman Z., Krajina Z., Krpan D., et al. Pilocarpine in the prevention of postirradiation xerostomia. Acta Med Croatica 53 (1999) 65-67
12. Haddad P., and Karimi M. A randomized, double-blind, placebo-controlled trial of concomitant pilocarpine with head and neck irradiation for prevention of radiation-induced xerostomia. Radiother Oncol 64 (2002) 29-32
13. Rode M., Smid L., Budihna M., et al. The effect of pilocarpine and biperiden on salivary secretion during and after radiotherapy in head and neck cancer patients. Int J Radiat Oncol Biol Phys 45 (1999) 373-378
14. Sangthawan D., Watthanaarpornchai S., and Phungrassami T. Randomized double blind, placebo-controlled study of pilocarpine administered during head and neck irradiation to reduce xerostomia. J Med Assoc Thai 84 (2001) 195-203
15. Warde P., O'Sullivan B., Aslanidis J., et al. A phase III placebo-controlled trial of oral pilocarpine in patients undergoing radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 54 (2002) 9-13
16. Gornitsky M., Shenouda G., Sultanem K., et al. Double-blind randomized, placebo-controlled study of pilocarpine to salvage salivary gland function during radiotherapy of patients with head and neck cancer. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 98 (2004) 45-52
17. Gorsky M., Epstein J.B., Parry J., et al. The efficacy of pilocarpine and bethanechol upon saliva production in cancer patients with hypo salivation following radiation therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 97 (2004) 190-195
18. Scarantino C., LeVeque F., Swann R.S., et al. Effect of pilocarpine during radiation therapy: Results of RTOG 97-09, a phase III randomised study in head and neck cancer patients. J Support Oncol 4 (2006) 252-258
19. Roesink J.M., Konings A.W.T., Terhaard C.H., et al. Preservation of the rat parotid gland function after radiation by prophylactic pilocarpine treatment: Radiation dose dependency and compensatory mechanisms. Int J Radiat Oncol Biol Phys 45 (1999) 483-489
20. Burlage F.R., Pijpe J., Coppes R.P., et al. Variability of flow rate when collecting stimulated human parotid saliva. Eur J Oral Sci 113 (2005) 386-390
21. LENT SOMA scales for all anatomic sites. Int J Radiat Oncol Biol Phys 31 (1995) 1049-1091
22. Coppes R.P., Roffel A.F., Zeilstra L.J.W., et al. Early to late sparing of the radiation damage to the parotid gland by adrenergic and muscarinic receptor agonists. Br J Cancer 85 (2001) 1055-1063
23. Coppes R.P., Meter A., Latumalea S.P., et al. Defects in muscarinic receptor-coupled signal transduction in isolated parotid gland cells after in vivo irradiation: Evidence for a non-DNA target of radiation. Br J Cancer 92 (2005) 539-546
24. Jellema A.P., Doornaert P., Slotman B.J., et al. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head and neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 (2005) 164-171